Oncology MarkersReferral Required
Circulating Tumour DNA Liquid Biopsy (523 genes)
Comprehensive genomic profiling of cell-free circulating tumour DNA, reporting actionable alterations, tumour mutational burden, and microsatellite instability. Ordered and interpreted by a treating oncology specialist as part of an active treatment plan — this is not a cancer screening test.
- Sample type
- Whole blood
- Turnaround
- 14–21 business days
- Fasting
- Not required
- Collection
- Collection centre only
What's measured (4 groups)
- 523-gene comprehensive genomic profile
- SNVs, indels, fusions, and copy-number alterations
- Blood tumour mutational burden (bTMB)
- Microsatellite instability (MSI-H) status
How to prepare
- A treating oncology specialist's order is required
- No fasting required
- Specialised collection tubes — collection-centre visit required
Partner accredited molecular oncology laboratory
Results are released to your Meridian Health account and can be shared with your treating clinician. Lab results are best interpreted alongside your clinical history — book a consultation if you'd like to review them with a doctor.
Book This Test
$2,780.00Sign in to book this lab test and choose a collection slot.